159 related articles for article (PubMed ID: 36396039)
1. Analytical approaches to evaluating hypertensive disorders of pregnancy.
Knupp RJ; Subramaniam A; Tita ANT; Sinkey R; Battarbee AN
Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100816. PubMed ID: 36396039
[TBL] [Abstract][Full Text] [Related]
2. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
Langenveld J; Broekhuijsen K; van Baaren GJ; van Pampus MG; van Kaam AH; Groen H; Porath M; Oudijk MA; Bloemenkamp KW; Groot CJ; van Beek E; van Huizen ME; Oosterbaan HP; Willekes C; Wijnen-Duvekot EJ; Franssen MT; Perquin DA; Sporken JM; Woiski MD; Bremer HA; Papatsonis DN; Brons JT; Kaplan M; Nij Bijvanck BW; Mol BW;
BMC Pregnancy Childbirth; 2011 Jul; 11():50. PubMed ID: 21736705
[TBL] [Abstract][Full Text] [Related]
3. A risk of waiting: the weekly incidence of hypertensive disorders and associated maternal and neonatal morbidity in low-risk term pregnancies.
Gibson KS; Waters TP; Bailit JL
Am J Obstet Gynecol; 2016 Mar; 214(3):389.e1-389.e12. PubMed ID: 26440691
[TBL] [Abstract][Full Text] [Related]
4. Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term.
Cluver C; Novikova N; Koopmans CM; West HM
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009273. PubMed ID: 28106904
[TBL] [Abstract][Full Text] [Related]
5. Is gestational age at term a risk factor for ongoing pregnancies in nulliparous women: A prospective cohort study.
Quibel T; Rozenberg P; Duvillier C; Bouyer C; Bouyer J
Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100808. PubMed ID: 36371036
[TBL] [Abstract][Full Text] [Related]
6. Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial.
Zwertbroek EF; Franssen MTM; Broekhuijsen K; Langenveld J; Bremer H; Ganzevoort W; van Loon AJ; van Pampus MG; Rijnders RJP; Sikkema MJ; Scherjon SA; Woiski MD; Mol BWJ; van Baar AL; Groen H;
Am J Obstet Gynecol; 2019 Aug; 221(2):154.e1-154.e11. PubMed ID: 30940558
[TBL] [Abstract][Full Text] [Related]
7. Maternal and neonatal outcomes of elective induction of labor.
Caughey AB; Sundaram V; Kaimal AJ; Cheng YW; Gienger A; Little SE; Lee JF; Wong L; Shaffer BL; Tran SH; Padula A; McDonald KM; Long EF; Owens DK; Bravata DM
Evid Rep Technol Assess (Full Rep); 2009 Mar; (176):1-257. PubMed ID: 19408970
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the maternal and perinatal sequelae of severe gestational hypertension.
Kumar NR; Grobman WA; Barry O; Clement AC; Lancki N; Yee LM
Am J Obstet Gynecol MFM; 2021 Jan; 3(1):100280. PubMed ID: 33451611
[TBL] [Abstract][Full Text] [Related]
9. Fetal growth patterns in pregnancy-associated hypertensive disorders: NICHD Fetal Growth Studies.
Mateus J; Newman RB; Zhang C; Pugh SJ; Grewal J; Kim S; Grobman WA; Owen J; Sciscione AC; Wapner RJ; Skupski D; Chien E; Wing DA; Ranzini AC; Nageotte MP; Gerlanc N; Albert PS; Grantz KL
Am J Obstet Gynecol; 2019 Dec; 221(6):635.e1-635.e16. PubMed ID: 31226296
[TBL] [Abstract][Full Text] [Related]
10. Maternal and neonatal characteristics associated with neonatal neutropenia in hypertensive pregnancies.
Sharma G; Nesin M; Feuerstein M; Bussel JB
Am J Perinatol; 2009 Oct; 26(9):683-9. PubMed ID: 19670129
[TBL] [Abstract][Full Text] [Related]
11. Sodium intake and the development of hypertensive disorders of pregnancy.
Bank TC; Grasch JL; Chung J; Mercer BM; McNeil RB; Parry S; Saade G; Shanks A; Silver RM; Simhan H; Yee LM; Reddy U; Grobman WA; Frey HA
Am J Obstet Gynecol MFM; 2023 Nov; 5(11):101166. PubMed ID: 37741626
[TBL] [Abstract][Full Text] [Related]
12. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
[TBL] [Abstract][Full Text] [Related]
13. Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension.
Greenberg VR; Silasi M; Lundsberg LS; Culhane JF; Reddy UM; Partridge C; Lipkind HS
Am J Obstet Gynecol; 2021 May; 224(5):521.e1-521.e11. PubMed ID: 33157064
[TBL] [Abstract][Full Text] [Related]
14. Association between insurance type and pregnancy outcomes in women diagnosed with hypertensive disorders of pregnancy.
Greiner KS; Speranza RJ; Rincón M; Beeraka SS; Burwick RM
J Matern Fetal Neonatal Med; 2020 Apr; 33(8):1427-1433. PubMed ID: 30182768
[No Abstract] [Full Text] [Related]
15. Differences in disease severity and delivery gestational age between black and white patients with hypertensive disorders of pregnancy.
Teal EN; Appiagyei A; Sheffield-Abdullah K; Manuck TA
Pregnancy Hypertens; 2022 Jun; 28():88-93. PubMed ID: 35290940
[TBL] [Abstract][Full Text] [Related]
16. ACC-AHA Diagnostic Criteria for Hypertension in Pregnancy Identifies Patients at Intermediate Risk of Adverse Outcomes.
Darwin KC; Federspiel JJ; Schuh BL; Baschat AA; Vaught AJ
Am J Perinatol; 2021 Aug; 38(S 01):e249-e255. PubMed ID: 32446257
[TBL] [Abstract][Full Text] [Related]
17. The optimal gestational age to deliver patients with chronic hypertension on antihypertensive therapy.
Jeganathan S; Blitz MJ; Makol AK; Juhel HS; Joseph A; Hentz R; Rochelson B; Rafael TJ
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2210727. PubMed ID: 37150597
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women.
Hauspurg A; Parry S; Mercer BM; Grobman W; Hatfield T; Silver RM; Parker CB; Haas DM; Iams JD; Saade GR; Wapner RJ; Reddy UM; Simhan H
Am J Obstet Gynecol; 2019 Sep; 221(3):277.e1-277.e8. PubMed ID: 31255629
[TBL] [Abstract][Full Text] [Related]
19. Hypertension in pregnancy and adverse outcomes among low-risk nulliparous women expectantly managed at or after 39 weeks: a secondary analysis of a randomised controlled trial.
Fishel Bartal M; Premkumar A; Murguia Rice M; Reddy UM; Tita ATN; Silver RM; El-Sayed YY; Wapner RJ; Rouse DJ; Saade GR; Thorp JM; Costantine MM; Chien EK; Casey BM; Srinivas SK; Swamy GK; Simhan HN;
BJOG; 2022 Jul; 129(8):1396-1403. PubMed ID: 34927787
[TBL] [Abstract][Full Text] [Related]
20. Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension.
Banala C; Moreno S; Cruz Y; Boelig RC; Saccone G; Berghella V; Schoen CN; Roman A
Am J Obstet Gynecol; 2020 Sep; 223(3):419.e1-419.e16. PubMed ID: 32173446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
